GABAergic | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

46 results for “GABAergic”

Trials

View all 21 →

Not yet recruiting

Association Between Serum and Neuroimaging Measurements of the GABAergic System

30 participants · First posted Jun 18, 2024

Imaging GABAergic/Glutamatergic Drugs in Bipolar Alcoholics Alcoholics

54 participants · First posted Jul 18, 2017

The GABAergic Inhibitory System in Drug Resistant Epilepsy

5 participants · First posted Jan 23, 2025

Drugs

hiPSCs derived SST-GABAergic interneuron progenitors

GABAergic gene therapy (AAV, Lennox-Gastaut syndrome)

allogenic induced pluripotent stem cell derived GABAergic neurons therapy (epilepsy)

News

View all 21 →

Ovid Therapeutics Reports Positive Phase 1 Results for OV329 in Drug-Resistant Epilepsy

Luye Pharma Initiates Phase 1 Trial for Novel Triple-Target Antidepressant LY03021

Gut-Brain Axis Emerges as Key Pathway in Parkinson's Disease Pathogenesis

Page 1 of 5